ARC expands Motherlabs in its west London hub

Brookfield’s life sciences spin-off ARC is expanding its Motherlabs in Hammersmith, W6. ARC’s new facility on the ground floor at the 150,000 sq ft lab Refinery is nearing completion and is expected to be ready for occupation later this year.   The Refinery will add more space for start-ups and seed companies after Motherlabs’ neighbouring facility at the Waterfront building reached full occupancy. Epsilogen, a developer of immunoglobulin E antibodies, took the remaining 1,500 sq ft suite in Motherlabs recently, as it continues to develop a new class of anti-cancer drug following successful clinical trials. The accelerator space is now home to Econic Biosciences, Sania Therapeutics, and GENinCode. Elsewhere in the building, Kesmalea Therapeutics has taken just over 3,600 sq ft of space.  Daniel Pagella, ARC’s senior director, said: “London is home to three of the world’s top 20 universities for life sciences, all of which are creating start-ups at record pace. It’s important that we provide our members with access to lab space and help them overcome the challenges of scaling to succeed at a global level.” ARC West London, formerly known as Manbré Wharf, is located close to Imperial College’s medical training and research campus within Charing Cross Hospital. The scheme provides a combined 240,000 sq ft of lab and office space. ARC launched Motherlabs in July 2022, offering an initial eight containment level 2 lab spaces across 11,000 sq ft at Waterfront building.  Lettings in Hammersmith >>